• 12003 Citations
  • 49 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Joo Hang Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Adenoviridae Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

  • 12003 Citations
  • 49 h-Index
  • 235 Article
  • 4 Review article
  • 3 Letter
  • 2 Comment/debate
3 Citations (Scopus)

Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC

Barlesi, F., Garon, E. B., Kim, D. W., Felip, E., Han, J. Y., Kim, J. H., Ahn, M. J., Fidler, M. J., Gubens, M. A., de Castro, G., Surmont, V., Li, Q., Deitz, A. C., Lubiniecki, G. M. & Herbst, R. S., May 1 2019, In : Journal of Thoracic Oncology. 14, 5, p. 793-801 9 p.

Research output: Contribution to journalArticle

Quality of Life
Health Status
5 Citations (Scopus)

Randomized phase III trial of irinotecan plus cisplatin versus etoposide plus cisplatin in chemotherapy-naïve Korean patients with extensive-disease small cell lung cancer

Kim, D. W., Kim, H. G., Kim, J. H., Park, K., Kim, H. K., Jang, J. S., Kim, B. S., Kang, J. H., Lee, K. H., Kim, S. W., Ryoo, H. M., Kim, J. S., Lee, K. H., Kwon, J. H., Choi, J. H., Shin, S. W., Hahn, S. & Heo, D. S., Jan 1 2019, In : Cancer Research and Treatment. 51, 1, p. 119-127 9 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Drug Therapy

Sonic hedgehog pathway as the prognostic marker in patients with extensive stage small cell lung cancer

Lim, S., Lim, S. M., Kim, M. J., Park, S. Y. & Kim, J. H., Oct 2019, In : Yonsei medical journal. 60, 10, p. 898-904 7 p.

Research output: Contribution to journalArticle

Open Access
Small Cell Lung Carcinoma
Disease-Free Survival
Confidence Intervals

STING signaling is a potential immunotherapeutic target in colorectal cancer

Chon, H. J., Kim, H., Noh, J. H., Yang, H., Lee, W. S., Kong, S. J., Lee, S. J., Lee, Y. S., Kim, W. R., Kim, J. H., Kim, G. & Kim, C., Jan 1 2019, In : Journal of Cancer. 10, 20, p. 4932-4938 7 p.

Research output: Contribution to journalArticle

Open Access
Colorectal Neoplasms
Gene Expression
4 Citations (Scopus)

Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune-checkpoint blockade

Chon, H. J., Lee, W. S., Yang, H., Kong, S. J., Lee, N. K., Moon, E. S., Choi, J., Han, E. C., Kim, J. H., Ahn, J. B., Kim, J. H. & Kim, C., Mar 1 2019, In : Clinical Cancer Research. 25, 5, p. 1612-1623 12 p.

Research output: Contribution to journalArticle

Oncolytic Viruses
Tumor Microenvironment
Vaccinia virus